Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis

M.T. Nurmohamed, Y. Bao, J. Signorovitch, A. Trahey, P. Mulani, D.E. Furst

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article numbere000080
JournalRMD Open
Issue number1
Publication statusPublished - 2015

Cite this